NCT04895605View on ClinicalTrials.gov

An Evaluation of Low Level Laser Light Therapy for Autistic Disorder 2

CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 11, 2020

Primary Completion Date

February 17, 2022

Study Completion Date

March 17, 2022

Conditions
Autistic Disorder
Interventions
DEVICE

Erchonia HLS Laser

The Erchonia HLS Laser emits a 640 nm (nanometer) wavelength with a tolerance of ±10 nm from each of two 7.5 mw (milliwatt) laser diodes.

DEVICE

Placebo Laser

The Placebo Laser emit the same visible light output as the active HLS Laser but without therapeutic effect.

Trial Locations (1)

02129

Spaulding Rehabilitation Hospital, Boston

Sponsors
All Listed Sponsors
lead

Erchonia Corporation

INDUSTRY